The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant - providing investors two common shares. Based on analyst projections, that amounts to a near-term 500% return potential.
 
ActivaTrade Logo
A special message from our valued partners and today's top market news.
Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant - providing investors two common shares. Based on analyst projections, that amounts to a near-term 500% return potential. Learn more and invest in HeartSciences.

Disclosure: This is a paid advertisement for HeartSciences`s Regulation A+ Offering. Please read the offering circular at https://invest.heartsciences.com/.
Elon Musk's Neuralink Implants Brain Chip In 6th Patient, Enables Paralyzed Man To Move Cursor, Play Game With His Mind

Neuralink implants BCI on 6th person, Rob Grenier, a quadraplegic man who can now play videogame with his thoughts. Continue Reading ➔
IRA & 401(K) Savers Are Scrambling To Get In - Ad

Hollywood elites think this is the moment you betray Trump. But they're wrong. His IRS is letting Americans use a little-known, 100% tax-free loophole to shield IRA, 401(k), and pension savings through this economic reset. Learn how to activate it with just 2 words. Rush me my free 2025 wealth protection guide now.
Over 200 Central Banks Reportedly Dump $48 Billion In US Treasuries Amid Concerns Over Dollar's Stability: 'The Drop Is Unusual'

Central banks and foreign entities have withdrawn a substantial amount of U.S. Treasuries from the New York Federal Reserve, signaling potential concerns over the stability of the U.S. dollar. Continue Reading ➔
Incyte's Experimental Therapy Shows Platelet Normalization And Safety In Rare Blood Cancer Trials Across Doses

Incyte's INCA033989 showed early efficacy and strong tolerability in essential thrombocythemia patients with mutCALR, supporting further development. Continue Reading ➔
The Edge Isn't You-It's Your System - Ad

HiveMind AI handles trades for you-based on logic, not gut instinct. Built by pro traders. Runs 24/7. No emotions. No second-guessing. Want to deploy capital smarter? See the system in action
Elizabeth Warren Challenges Plan To Bring Private Equity Into 401(k)s, Citing Transparency And Fee Concerns

Senator Elizabeth Warren raises concerns about retirement plan provider's plan to offer private equity investments in 401(k) accounts, citing potential risks and lack of transparency. Continue Reading ➔
North Korea plans to send military construction workers and deminers to Russia

SEOUL, South Korea (AP) — North Korea will send thousands of military construction workers and deminers to support reconstruction work in Russia’s Kursk region, a top Russian official said Tuesday, the latest sign of between the two nations. Continue Reading ➔
GOP Budget Bill Plans To Sell Over 2 Million Acres Of Public Land Across 11 States, Faces Pushback From Lawmakers And Conservationists

Republican budget bill proposes sale of 2 million acres of public land, facing opposition from conservation groups, hunting orgs, local officials. Continue Reading ➔
US Restarts Student Visas With Mandatory Social Media Access Amid Marco Rubio's AI-Driven 'Catch And Revoke' Initiative Targeting Foreign Applicants

The State Department has restarted foreign student visa processing after a month-long suspension, implementing new screening requirements that mandate applicants provide access to their social media accounts for government review. Continue Reading ➔
America's No. 1 AI Dividend Stock Revealed - Ad

Marc Lichtenfeld has just gone public with his No. 1 AI dividend stock. in his new "AI Income Playbook", you'll discover why this firm has become Marc Lichtenfeld's "No. 1 AI dividend stock"... Including its name, ticker symbol, and a full breakdown of its AI profit potential. Claim your FREE copy of Marc's AI playbook.
Mark Zuckerberg's Meta Dangled '$100 Million Signing Bonuses' To OpenAI Team Members, Says Sam Altman: Happy 'None' Of Our Best People Took Them

OpenAI CEO Sam Altman says Meta tried to poach his top researchers with $100 million offers, but none left, believing OpenAI has a better shot at achieving AGI. Continue Reading ➔
A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

All 50 U.S. states have agreed to the OxyContin maker ’s latest plan to settle thousands of lawsuits over the . Continue Reading ➔
Elon Musk's Bombshell About Donald Trump in Epstein Docs: Here's the Truth Behind the Claim

Elon Musk's claim regarding President Trump's connection to the undisclosed Jeffrey Epstein files has ignited a political uproar. Continue Reading ➔
Amazon Retrains Warehouse Workers For Satellite Jobs: 'It Really Is Life-Changing,' Says Project Kuiper Technician

Amazon.com Inc. is transforming warehouse workers into satellite technicians through education partnerships. Continue Reading ➔
Elon Musk's SpaceX Suffers Major Setback As Starship Rocket Explodes In Static Fire Test

SpaceX's Starship 36 rocket exploded during a pre-flight static fire test at Starbase. No injuries reported, incident under investigation. Continue Reading ➔
Elon Musk's xAI May Face 'Clean Air Act' Lawsuit Over Alleged Pollution At Memphis Data Center

The data center operated by Elon Musk's xAI in Memphis is facing potential legal action for running a fleet of natural gas turbines without the necessary permits. Continue Reading ➔
Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040
© 2025 Musth | ActivaTrade | All rights reserved.

Unsubscribe